1. Home
  2. LCID vs KNSA Comparison

LCID vs KNSA Comparison

Compare LCID & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$9.91

Market Cap

3.7B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$48.54

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
KNSA
Founded
2007
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.5B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
LCID
KNSA
Price
$9.91
$48.54
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$19.67
$55.29
AVG Volume (30 Days)
5.0M
539.0K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
225.00
EPS
N/A
0.75
Revenue
$595,271,000.00
$677,564,000.00
Revenue This Year
$70.41
$38.01
Revenue Next Year
$92.93
$17.42
P/E Ratio
N/A
$65.09
Revenue Growth
N/A
60.09
52 Week Low
$1.97
$18.26
52 Week High
$25.22
$49.33

Technical Indicators

Market Signals
Indicator
LCID
KNSA
Relative Strength Index (RSI) 49.26 62.30
Support Level $9.38 $41.55
Resistance Level $10.82 N/A
Average True Range (ATR) 0.49 1.66
MACD -0.03 0.20
Stochastic Oscillator 48.63 89.75

Price Performance

Historical Comparison
LCID
KNSA

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: